Liquid Biopsy:
Comprehensive
Individual
cancer diagnostics
iQMedix exists to improve the lives of cancer patients. Every person is unique, and every cancer is unique. Our approach includes an in-depth molecular analysis of the patient from a liquid biopsy, which enables the doctor to develop the best therapies.
Our Approach
Determination of gene expression profiles from circulating tumor cells by liquid biopsy
Every tumor is different. It is therefore essential to obtain as much information as possible about your individual cancer.
Molecular profiling from a painless liquid biopsy can detect specific signals in your tumor. Based on these signals, your medical team can determine whether certain drugs or therapies might work well in treating your cancer.
iPrevent
Early recognition and action
The iPrevent test based on a blood sample enables an early and cost-effective check to detect hidden cancer activity in your body even before an imaging procedure can detect it. Gain peace of mind with liquid biopsy and act early.
- A simple blood sample is used
- Circulating tumor cells are determined
- Very high accuracy for early detection
iSelect
for natural substances and off-label drugs
The iSelect test separates circulating blood cells from your liquid biopsy blood sample. From these, the activity level of more than 80 important genes of your tumor is determined. This is used to determine which natural and off-label substances can be effective for your tumor.
- Only a simple blood sample is needed
- Increased signals and metabolic pathways are determined on the basis of gene expressions
- We provide you with a report that suggests complementary therapy options that your medical team can implement
iComplete
For comprehensive therapy options
The iComplete test separates circulating blood cells from your liquid biopsy blood sample. From these, the activity level of more than 80 important genes of your tumor is determined. This is used to determine which authorized drugs(chemotherapeutic agents, targeted drugs and immunotherapies), as well as Natural and off-label substances can be effective for your tumor.
- Only a simple blood sample is needed
- Increased signals and metabolic pathways are determined on the basis of gene expressions
- We provide you with a report that suggests comprehensive treatment options that your medical team can implement
Our commitment
Vision
Our vision is a world in which cancer becomes a manageable disease, thanks to personalized therapeutic approaches based on innovative genomic research that give every patient hope, a cure and a fulfilling life.
Mission
We use the latest developments in biotechnology to understand cancer as fully as possible and use this knowledge to outwit and defeat it.
News
News
SAVE THE DATE: iQMedix Medical Congress
Our medical congress will take place on Saturday, May 10, 2025 from 10 a.m. to 5 p.m. in our offices. The topic of the congress is: Modern personalized tumor therapy in the
We are looking for you!
iQMedix is a young and fast-growing medical laboratory in Mannheim that uses innovative liquid biopsy diagnostics to perform gene expression tests on circulating tumor cells for oncological patients
Visit us at the Medical Week in Baden-Baden
We are looking forward to exhibiting at the Medical Week next week. The Medical Week will take place from 30.10-3.11.24: https://www.medizinische-woche.de/home You can look forward to
Meet us at the DGHO in Basel
Meet us at the annual meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology (DGHO). The conference will take place from 11 to
iQMedix at the XI DGHT Congress, 04.-05.10.2024
The German Society for Hyperthermia e.V. is organizing the XI Hyperthermia Congress from 4 to 5 October 2024 under the motto "Cooperation for interdisciplinary cancer therapy". On
Get in touch with us!
Gain precise insights into your cancer with us!
Our address
iQMedix GmbH
Franz-Volhard-Str. 5
68167 Mannheim
Talk to us:
fAQ
frequently asked questions
Do you have any questions? Talk to us!
The analysis of gene expression values enables a detailed characterization of tumor cells and can help to understand the metabolic and signaling activities of the tumor, predict its progression and develop personalized therapeutic approaches.
The test provides information about the patterns of gene activity involved in the development of cancer. This can provide information about the manipulation of the immune system by the tumor, resistance to drugs, the activity of relevant signals and possible therapeutic approaches.
Usually become the Tumor cells from one Blood sample Extractt, followed by analysis of the mRNA to determine the activity of genes. The tumor cells can also be obtained from a biopsy, from urine, Liqor or ascites are removed.
The blood sample can be taken by your doctor and is a minor, largely painless procedure.
The results can help their medical team create personalized treatment plans by selecting therapies that target the specific genetic characteristics of the tumor.
We offer the iPrevent test as a preventive test. This test looks for the presence of tumor cells in the blood sample. If these are present in increased numbers, this indicates an active tumor in the body. In this case, a complete gene expression test can be connected and early action can be taken to combat the tumor.
The costs vary depending on the complexity of the testing and the technologies used. In some cases, these costs can be covered by insurance. Talk to us, we will be happy to provide information at any time.
The duration depends on the specific test. The results are usually available within two weeks.
Reliability depends on several factors, including the test method and the quality of the sample taken. In many cases, liquid Biopsy-tests are a reliable addition to other diagnostic methods.
